Cover Image

Evaluation of Serum Metalloprotinase-9 (MMP-9) in Iraqi Men with urinary tract infection

Hanan D. Abbas


Objective: The inflammation of the urinary tract and its various causes is one of the important diseases, which neglect and non-treatment lead to many amplifications, therefore, many countries including the United States of America has given urinary tract infection UTI a great interest. Since the disease is sometimes without obvious symptoms and because of research lacking that are using MMP-9. The aim of this work is to study the alterations in the Metalloprotinase-9 (MMP-9), and its role in pathogenicity of urinary tract infections ″UTI″ in serum of men who are initially diagnosed with this disease.

Methods: This study was applied in educational Alsader hospital in Najaf city by using Enzyme Linked Immuno Sorbent Assay (ELISA) on serum taken from 42 men infected with UTI, and other 38 healthy considered as a control group to detect MMP-9.

Data analysis: SPSS computerizing system has been used for statistically analysis of data.

Results: The results revealed a highly significant (P<0. 05) level of ″MMP-9″in serum of patients in comparison with the control group. The result also demonstrated the strong relation between MMP-9 and other parameters such as age and smoking.

Conclusion: It was concluded from the results of the present study thatMetalloprotinase-9″MMP-9″ was good prognostic biomarker for ″UTI″ in men, and these results significantly correlate with the early stages of disease.

Recommendation: 1-It may be recommended that using MMP-9 to predict and diagnosis the urinary tract infection. 2-It may be also recommended to measure MMP-9 in women to establish its role in this disease



MMP-9, UTI, Iraqi men, Serum, ELISA

Full Text:



William C. P., Carole L. W. and Yolanda S. L. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology, 4, (2004), 617-62.

Yu W. H., Woessner J. F., McNeish J. D., Stamenkovic I. and Genes D. D44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev, 16(3), (2002), 307-23.

Klein T. And Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids, 41(2), (2011), 271-290.

Stuelten C. H., Byfield S. D. Arany P. R., Karpova T. S., Stetler-Stevenson W. G. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGFbeta. J Cell Sci, 118, (2005), 2143-2153.

Overall C. M. and López-Otín C. “Strategies for MMP inhibition in cancer: innovations for the post-trial era” Nature Reviews Cancer, vol. 2, no. 9, (2002), pp. 657–672.

Salvatore S. Salvatore S. Cattoni E. Siesto G. Serati M. M "Urinary tract infections in women". European journal of obstetrics, gynecology, and reproductive biology. 156 (2), (2011), 131–6.

Woodford, H. J. George J. "Diagnosis and management of urinary infections in older people". Clinical Medicine. London. 11 (1), (2011), 80–3.

Flores-Mireles A L., Walker J N., Caparon M., Hultgren S J. "Urinary tract infections: epidemiology, mechanisms of infection and treatment options” Nature Reviews. Microbiology. 13 (5), (2015), 269–84.

Introduction to medical surgical nursing. Elsevier Health Sciences. (2015), p. 909.

Jarvis A and William R. Bennett & Brachman's hospital infections. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, (2007), p. 474.

Colgan R, Williams M, Johnson JR. "Diagnosis and treatment of acute pyelonephritis in women". American family physician. 84 (5), (2011), 519–26.

Leung and David Hui. Approach to internal medicine: a resource book for clinical practice. New York: Springer, (2016), p. 244.

Brunner and Suddarths. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, (2010), p. 1359.

Hatipoglu S., Sevketoglu E., Gedikbasi A., Yilmaz A., Kiyak A. Urinary MMP-9/NGAL complex in children with acute cystitis. Pediatr Nephrol., 26(8), (2011), 1263-8.

Malla N., Sjoli S., Winberg J. O, Hadler-Olsen E., Uhlin-Hansen L. Biological and pathological functions of gelatinase dimers and complexes. Connect Tissue Res, 49, (2008), 180-4.

Van den Steen P. E., Dubois B., Nelissen I., Rudd PM., Dwek RA. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9) Crit. Rev. Biochem. Mol. Biol., 37, (2002), 375-536.

Knäuper V. and Murphy G. “Methods for studying activation of matrix metalloproteinases” Methods in Molecular Biology, vol. 622, (2010), pp. 233–243.

Hadler-Olsen E., Fadnes B., Sylte I., Uhlin-Hansen L., and Winberg J. “Regulation of matrix metalloproteinase activity in health and disease”, FEBS Journal, vol. 278, no. 1, (2011), pp. 28–45.

Lynch C. and Matrisian L. “Matrix metalloproteinases in tumor-host cell communication” Differentiation, vol. 70, no. 9-10, (2002), pp. 561–573.

Fernandez-Catalan C., Bode W., Huber R. “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase a receptor”, The EMBO Journal, vol. 17, no. 17, (1998), pp. 5238–5248.

Huda S J. Urinary level of matrix metalloprotinase (MMP-9) as abiomarker in cystitis and schistosomal chronic cystitis patients.

Brinckerhoff C. and Matrisian L “Matrix metalloproteinases: a tail of a frog that became a prince” Nature Reviews Molecular Cell Biology, vol. 3, no. 3, (2002), pp. 207–214.

Sternlicht M. and Werb Z. “How matrix metalloproteinases regulate cell behavior” Annual Review of Cell and Developmental Biology, vol. 17, (2001), pp. 463–516.

Carlo A D. Terracciano D. Mariano A. et al., Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors, Oncology Reports, vol. 15, no. 5, (2006), pp. 1321-1326.

Otero-Estévez O. De Chiara L. Rodríguez-Girondo M. Rodríguez-Berrocal F. Cubiella J. Serum matrix metalloproteinase-9 in colorectal cancer family risk population screening, Scientific Reports 5, Article number, (2015), 13030.

Inga. S., Christer J., Lars Land Johannes H. Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: A population based study. Respirology, 15(3), (2010), 530-535.



  • There are currently no refbacks.

Copyright (c) 2017 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.